News archive

In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet will now lead an international collaboration project on pharmacovigilance – drugs safety – in four countries in East Africa.

Procome a partner in an Erasmus educational program for implementation science.

The research group Procome receives research funding from FORTE for a three year project investigating how evidence-based interventions can give the best value for service users. It’s a collaboration with the local the R&D units (FoU Nordväst,FoU nordostoch FOU nu) and social service organizations.

Katja Petzold has received the Ampere prize for Young Investigators during the EUROMAR conference in Nantes, France. The prize of 3,000 EUR was given in recognition of her achievements in using solution-state nuclear magnetic resonance spectroscopy (NMR) for the study the molecular mechanism of RNA function.

As soon as a baby is born, its immune system starts to change dramatically in response to the bacteria, viruses and so forth in its new environment, a phenomenon that is common to all babies, researchers from Karolinska Institutet in Sweden write in a paper published in Cell. The study was made possible using new techniques of immune cell analysis.

Successful pathogenic strains of pneumococci have two proteins that, owing to their location on the surface of the bacteria, enhance their survival and ability to cause disease, a study from Karolinska Institutet in Sweden published in Nature Communications, reports.

Failure to generate neutrophils in the bone marrow leads to devastating bacterial and fungal infections. Researchers from Karolinska Institutet have discovered a new pathway to elevate the number of tissue neutrophils by activating the cell cytoskeleton. The study is published in Journal of Clinical Investigation.

Receptor pharmacologists investigate how the body’s own transmitter substances and exogenous drugs affect cellular receptors to mediate and affect bodily functions.

People who carry genes that make them more susceptible to developing multiple sclerosis (MS) are at much greater risk of developing the disease if they have been exposed to paint, varnish and other solvents, according to a new study from Karolinska Institutet published in the journal Neurology. If they have also been smokers, the risk of developing MS is multiplied.